Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 5 | +1.47M | 99.3% | $28.17 | +$41.4M |
Sells | 1 | -11K | 0.7% | $41.79 | -$460K |
Net | +4 | +1.46M | 98.5% | +$41M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
John W. Childs | Director | $230M | +$21M | +10% | Jul 18, 2024 |
Vlad Coric | Chief Executive Officer, Director | $129M | +$15M | +13.2% | Apr 22, 2024 |
Gregory Bailey | Director | $55.2M | +$3.91M | +7.63% | May 13, 2024 |
Matthew Buten | Chief Financial Officer | $4.17M | +$500K | +13.6% | Jan 2, 2024 |
Bruce Car | Chief Scientific Officer | $1.09M | +$1.01M | +1259% | Jun 17, 2024 |
Irina Antonijevic | Director | $106K | -$460K | -81.3% | Apr 30, 2024 |
Kishan Mehta | Director | Apr 30, 2024 | |||
George Clark | VP, Chief Accounting Officer | Jan 2, 2024 | |||
Robert J. Hugin | Director | Apr 30, 2024 | |||
Michael Thomas Heffernan | Director | Apr 30, 2024 | |||
Biohaven Pharmaceutical Holding Co Ltd. | 10%+ Owner | Oct 3, 2022 | |||
Julia P. Gregory | Director | Apr 30, 2024 | |||
Kimberly Gentile | SVP, Clinical Operations | Jan 2, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|